COMMUNIQUÉS West-GlobeNewswire

Actuate Therapeutics Announces Plans to Expand Clinical Pipeline, Advancing Elraglusib Tablet into a Phase 1/2 Clinical Program in Refractory Cancers
21/01/2026
-Initiation of phase 1 portion of the trial planned in 2H 2026 -Phase 2 portion of the trial will initiate development of the elraglusib tablet in specific indications, including refractory melanoma and additional [...]
LiveWorld Announces Human-Led, AI-Powered Strategy & 2026 Solutions Roadmap
21/01/2026
Company Unveils Seven AI Solutions for 2026, Built for The New Era of Healthcare Marketing CAMPBELL, Calif. and NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- LiveWorld, Inc. (OTC Markets: LVWD). For nearly three decades, [...]
Human Continuum Appoints Dr. Tsun “Sean” Law MD, MBA as its Chief Executive Officer to Lead the Research and Development Efforts Focused on Next-Generation Exosome Therapies and Over-the-Counter Exosome-based Products
21/01/2026
New York, N.Y., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”) , a developer of platelet-derived and plant-based exosome therapeutics and diagnostics, today announced that it has [...]
PerfectServe is Furthest in Vision and Highest in Execution in 2026 Gartner® Magic Quadrant™ for Clinical Communication and Collaboration
21/01/2026
Marks the company’s third consecutive placement as a Leader following recognition as highest in execution in 2023 and furthest in vision in 2024 KNOXVILLE, Tenn., Jan. 21, 2026 (GLOBE NEWSWIRE) -- PerfectServe ® , a [...]
Manhattan Wellness Joins Lumina Therapy Alliance, Expanding the Nation’s Premier In-Person Mental Health Network
21/01/2026
Led by visionary founder Jennifer Teplin, Manhattan Wellness strengthens Lumina’s footprint for New York’s business community and signals rapid national expansion. NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Lumina [...]
“Medical Travel Month” January 2026 Sponsored by Medical Travel & Digital Health News in SHSMD American Hospital Association’s Calendar of Health Observances
21/01/2026
OAKLAND, N.J., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Medical Travel & Digital Health News (MTDHN) , the leading bi-monthly online newsletter covering the business of medical travel and digital solutions worldwide, today [...]
Philips named a Clarivate Top 100 Global Innovator for the 13th consecutive year
21/01/2026
January 21, 2026 Highest-ranking medical technology company recognized in the Clarivate Top 100 Global Innovators list for 2026 Innovations for healthcare professionals and consumers that support better care delivery [...]
IO Biotech Announces Exploration of Strategic Alternatives
21/01/2026
NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that the [...]
Comphya Announces Publication of CaverSTIM First-in-Man Clinical Study in BJUI and Scientific Review in Nature Urology
21/01/2026
Peer-reviewed publications validate the scientific foundation and early clinical potential of CaverSTIM™ in restoring erectile function LAUSANNE, Switzerland, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Comphya SA , a clinical- [...]
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2025
21/01/2026
Company Announcement Net sales of DARZALEX ® in 2025 totaled USD 14,351 million Genmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc.) COPENHAGEN, [...]
AnswersNow Completes $40M Series B to Expand BCBA-Driven, AI-Enabled Autism Therapy
21/01/2026
RICHMOND, Va., Jan. 21, 2026 (GLOBE NEWSWIRE) -- AnswersNow , the leader in virtual Applied Behavioral Analysis (ABA) therapy, today announced that it has raised $40 million in Series B funding led by HealthQuest [...]
Lisata Therapeutics Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer
21/01/2026
Stockholders to also receive two contingent value rights valued at $1 per share, each entitled to be received upon the achievement of certain milestones Offer represents an approximate 85% premium over the most recent [...]
Ocular Therapeutix™ Appoints David W. Robinson as Global Chief Commercial Officer
21/01/2026
Accomplished global commercial leader with deep expertise in retina drug launches Primary architect for the industry-defining launch of EYLEA ® while at Regeneron Most recently served as Chief Marketing Officer, Global [...]
Skye Bioscience to Present Poster at Keystone Obesity Conference
21/01/2026
SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health [...]
Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings
21/01/2026
REDWOOD CITY, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced that it will present a [...]
FDA Granted Hopstem’s hNPC01 for Chronic Ischemic Stroke Approval to Enter Phase 2/3 Adaptive Pivotal Clinical Trial with Bridging Study
21/01/2026
HOUSTON, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Hopstem Biotechnology Inc. (hereinafter referred to as "Hopstem"), a company dedicated to the development of induced pluripotent stem cell (iPSC)-derived allogeneic neural cell [...]
Crucial Innovations Corp. Launches 4TP, a New Patient-Focused Brand of Cannabis-Based Products for Medicinal Use
21/01/2026
4TP (“For The People”) introduces carefully cultivated CBPMs supported by transparent education and a commitment to consistent high-quality medicine LONDON, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Crucial Innovations Corp. ( [...]
Angelini Pharma Announces Appointment of Sergio Marullo di Condojanni as New CEO
21/01/2026
CEO of family company Angelini Industries will also lead the pharmaceutical company from today, bringing strong leadership experience and strategic vision ROME, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Angelini Pharma, part of [...]
AMSilk’s bioengineered silk protein yarns debut in Balenciaga Spring 2026 Collection
21/01/2026
First commercially available products using AMSilk’s biotech silk protein yarns Demonstrating a scalable, low impact alternative to conventional silk within luxury fashion Designed for resilient, transparent and [...]

Pages